Informationen:
Fehler:
ID
31874
Beschreibung
A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00810199
Link
https://clinicaltrials.gov/show/NCT00810199
Stichworte
Versionen (1)
- 05.10.18 05.10.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
5. Oktober 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Rheumatoid Arthritis NCT00810199
Eligibility Rheumatoid Arthritis NCT00810199
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Rheumatoid Arthritis NCT00810199
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Adult | Age
Item
adult patients, ≥ 18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Rheumatoid arthritis moderate Disease activity score das28 | Rheumatoid Arthritis Severe Disease activity score das28
Item
moderate to severe active rheumatoid arthritis (disease activity score (das28) > 4.4);
boolean
C2368567 (UMLS CUI [1,1])
C4481729 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C4481729 (UMLS CUI [2,3])
C4481729 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C4481729 (UMLS CUI [2,3])
Methotrexate Response Inadequate
Item
inadequate response to methotrexate;
boolean
C0025677 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
Methotrexate Dose Stable U/week
Item
on a stable dose of ≥ 15mg/week methotrexate for at least 6 weeks.
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
Biological agent
Item
prior treatment with a biologic;
boolean
C0005515 (UMLS CUI [1])
Rheumatoid Arthritis Functional Status Class
Item
rheumatoid arthritis (ra) functional class iv;
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Bacterial Infections | Virus Diseases | Mycoses | Mycobacterial Infections | Communicable Diseases | Recurrent bacterial infection | Recurrent viral infection | Recurrent fungal infections | Recurrent mycobacterial infections | Recurrent infections
Item
known active current or history of recurrent bacterial, viral, fungal, mycobacterial or other infections;
boolean
C0004623 (UMLS CUI [1])
C0042769 (UMLS CUI [2])
C0026946 (UMLS CUI [3])
C0026918 (UMLS CUI [4])
C0009450 (UMLS CUI [5])
C1844383 (UMLS CUI [6])
C1837066 (UMLS CUI [7])
C1844384 (UMLS CUI [8])
C4023438 (UMLS CUI [9])
C0239998 (UMLS CUI [10])
C0042769 (UMLS CUI [2])
C0026946 (UMLS CUI [3])
C0026918 (UMLS CUI [4])
C0009450 (UMLS CUI [5])
C1844383 (UMLS CUI [6])
C1837066 (UMLS CUI [7])
C1844384 (UMLS CUI [8])
C4023438 (UMLS CUI [9])
C0239998 (UMLS CUI [10])
Malignant Neoplasms
Item
evidence of active malignant disease.
boolean
C0006826 (UMLS CUI [1])